SpecGx LLC
✅ Low Risk
FEI: 1419579 • Greenville, IL • UNITED STATES
FEI Number
1419579
Location
Greenville, IL
Country
UNITED STATESAddress
100 Louis Latzer Dr, , Greenville, IL, United States
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/30/2014 | 62GCZ41IBUPROFEN (ANTI-INFLAMMATORY) | 118NOT LISTED | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is SpecGx LLC's FDA import refusal history?
SpecGx LLC (FEI: 1419579) has 1 FDA import refusal record(s) in our database, spanning from 4/30/2014 to 4/30/2014.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SpecGx LLC's FEI number is 1419579.
What types of violations has SpecGx LLC received?
SpecGx LLC has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about SpecGx LLC come from?
All FDA import refusal data for SpecGx LLC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.